These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 30332284

  • 1. Expression of endothelin type B receptors (EDNRB) on smooth muscle cells is controlled by MKL2, ternary complex factors, and actin dynamics.
    Krawczyk KK, Skovsted GF, Perisic L, Dreier R, Berg JO, Hedin U, Rippe C, Swärd K.
    Am J Physiol Cell Physiol; 2018 Dec 01; 315(6):C873-C884. PubMed ID: 30332284
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
    Kimura TE, Duggirala A, Smith MC, White S, Sala-Newby GB, Newby AC, Bond M.
    J Mol Cell Cardiol; 2016 Jan 01; 90():1-10. PubMed ID: 26625714
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nexilin/NEXN controls actin polymerization in smooth muscle and is regulated by myocardin family coactivators and YAP.
    Zhu B, Rippe C, Holmberg J, Zeng S, Perisic L, Albinsson S, Hedin U, Uvelius B, Swärd K.
    Sci Rep; 2018 Aug 29; 8(1):13025. PubMed ID: 30158653
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization.
    Patel K, Harding P, Haney LB, Glass WF.
    J Cell Physiol; 2003 Jun 29; 195(3):435-45. PubMed ID: 12704653
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes.
    Zeidan A, Javadov S, Karmazyn M.
    Cardiovasc Res; 2006 Oct 01; 72(1):101-11. PubMed ID: 16901475
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J, Jiang J, Yin H, Wang L, Tian R, Li H, Wang Z, Li D, Wang Y, Gui Y, Walsh MP, Zheng XL.
    Hypertension; 2012 Jul 01; 60(1):145-53. PubMed ID: 22615115
    [Abstract] [Full Text] [Related]

  • 13. Cooperative signaling by TGF-β1 and WNT-11 drives sm-α-actin expression in smooth muscle via Rho kinase-actin-MRTF-A signaling.
    Kumawat K, Koopmans T, Menzen MH, Prins A, Smit M, Halayko AJ, Gosens R.
    Am J Physiol Lung Cell Mol Physiol; 2016 Sep 01; 311(3):L529-37. PubMed ID: 27422998
    [Abstract] [Full Text] [Related]

  • 14. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
    Shikatani EA, Chandy M, Besla R, Li CC, Momen A, El-Mounayri O, Robbins CS, Husain M.
    Arterioscler Thromb Vasc Biol; 2016 Jul 01; 36(7):1367-76. PubMed ID: 27174098
    [Abstract] [Full Text] [Related]

  • 15. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
    Liu HW, Halayko AJ, Fernandes DJ, Harmon GS, McCauley JA, Kocieniewski P, McConville J, Fu Y, Forsythe SM, Kogut P, Bellam S, Dowell M, Churchill J, Lesso H, Kassiri K, Mitchell RW, Hershenson MB, Camoretti-Mercado B, Solway J.
    Am J Respir Cell Mol Biol; 2003 Jul 01; 29(1):39-47. PubMed ID: 12600823
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A.
    Oncogene; 1997 Jan 16; 14(2):213-21. PubMed ID: 9010223
    [Abstract] [Full Text] [Related]

  • 18. Suppression of smooth muscle cell inflammation by myocardin-related transcription factors involves inactivation of TANK-binding kinase 1.
    Bankell E, Liu L, van der Horst J, Rippe C, Jepps TA, Nilsson BO, Swärd K.
    Sci Rep; 2024 Jun 10; 14(1):13321. PubMed ID: 38858497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.